Intellia Therapeutics
Brian Lynch is a seasoned financial professional with extensive experience in financial reporting, technical accounting, and internal controls. Currently serving as Senior Director at Intellia Therapeutics, Inc. since July 2019, Brian has held various director roles within the company. Prior to this, Brian spent over a decade at Deloitte & Touche, advancing from Audit Senior to Audit Senior Manager. Brian holds a Master of Science in Accounting from Babson F.W. Olin Graduate School of Business and a Bachelor of Science in Accounting from Babson College.
This person is not in any teams
This person is not in any offices
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.